Institutional Ownership
Xenon Pharmaceuticals Inc
CUSIP 98420N105COMXENEQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).